For more information, visit www.miltenyibiotec.com/DE-en/... This webinar will delve into the challenges associated with translating workflows into a GMP-compliant environment, with a specific focus on regenerative medicine in cardiovascular diseases. Specific discussion will focus on the pre-clinical development path, and hurdles related to supply chain raw materials management, and identifying equipment compatible with the execution of novel, compliant manufacturing processes. Learn how the MACSQuant® Tyto®, with its closed and sterile cell sorting system, is the ideal solution for easily translating workflows from the research bench to clinical manufacturing.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,500 employees in 28 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.